CRL (Charles River Lab) Earnings per share for the last four quarters

Public company logo of Charles River Laboratories International, Inc. (CRL)

The Charles River Laboratories (CRL) strategy is based on increasing order volume and margins within the DSA segment. The annual EPS growth rate over the last 12 months on the GURU.Markets chart demonstrates progress in this direction, where 165.30 reflects the baseline level of the metric. Development is constrained by the complexities of establishing joint research centers, although global demand for testing offsets geopolitical risks.

CRL Charles River: Net earnings per share (EPS TTM) in the range 02/11/2024 - 11/16/2026

Charles River Corp - analytical breakdowns and key metrics (CRL)

- market price and analyst price targets:
- business market valuation indicators:
Product sample of Charles River Lab

This indicator measures the rate of change in earnings per share over the last twelve months, reflecting the efficiency of capital generation relative to previous periods. By analyzing the historical year-over-year EPS (TTM) growth, investors assess how the diversified contracts of Charles River Laboratories (CRL) with the biotech sector and pharma behemoths convert into real financial growth and a sustainable increase in shareholder value.